---
$id: https://graph.org.ai/products/commodity/51282925
$type: Product
source: UNSPSC
code: "51282925"
title: "Irloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Irloxacin

**UNSPSC Code**: 51282925
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C16H13FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36SG77D21B, chemically known as 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1h-pyrrol-1-yl)-3-quinolinecarboxylic acid but generally known as irloxacin, which bears US NIH Compound Identifier 65828. European Medicines Agency schedules Irloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08296MIG. The term IRLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). IRLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule irloxacin under HS 29334990 and SITC 51575. As of Q4 2014, IRLOXACIN remains the US FDA Preferred Term for this commodity. Irloxacin bears US NLM identifiers UMLS ID C0071133 and NCI Concept Code C65961. SMILES: FC1C(N2CCCC2)CC2N(CC)CC(C(=O)C2C1)C(=O)O.

